TRPC7
geneOn this page
Summary
TRPC7 (transient receptor potential cation channel subfamily C member 7, HGNC:20754) is a protein-coding gene on chromosome 5q31.1, encoding Short transient receptor potential channel 7 (Q9HCX4). Forms a receptor-activated non-selective calcium permeant cation channel.
Predicted to enable inositol 1,4,5 trisphosphate binding activity and store-operated calcium channel activity. Predicted to be involved in calcium ion transmembrane transport; regulation of cytosolic calcium ion concentration; and single fertilization. Predicted to be located in membrane; nuclear envelope; and perinuclear region of cytoplasm. Predicted to be part of cation channel complex. Predicted to be active in plasma membrane. Implicated in lung cancer.
Source: NCBI Gene 57113 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 109 total
- Druggable target: yes
- MANE Select transcript:
NM_020389
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20754 |
| Approved symbol | TRPC7 |
| Name | transient receptor potential cation channel subfamily C member 7 |
| Location | 5q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000069018 |
| Ensembl biotype | protein_coding |
| Entrez | 57113 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000352189, ENST00000378459, ENST00000502753, ENST00000503275, ENST00000509288, ENST00000513104, ENST00000514963
RefSeq mRNA: 4 — MANE Select: NM_020389
NM_001167576, NM_001167577, NM_001376901, NM_020389
CCDS: CCDS47267, CCDS54905, CCDS54906, CCDS93787
Canonical transcript exons
ENST00000513104 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002055508 | 136212745 | 136213604 |
| ENSE00002077005 | 136356608 | 136357385 |
| ENSE00002351005 | 136274673 | 136274837 |
| ENSE00002410827 | 136315597 | 136315779 |
| ENSE00003513924 | 136216200 | 136216275 |
| ENSE00003526390 | 136226034 | 136226255 |
| ENSE00003581155 | 136266220 | 136266436 |
| ENSE00003583424 | 136247471 | 136247735 |
| ENSE00003617190 | 136251649 | 136251882 |
| ENSE00003658857 | 136231354 | 136231549 |
| ENSE00003679689 | 136225274 | 136225354 |
| ENSE00003899944 | 136365253 | 136365545 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 95.49.
Top tissues by expression
224 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 95.49 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.00 | gold quality |
| secondary oocyte | CL:0000655 | 76.98 | gold quality |
| cortical plate | UBERON:0005343 | 61.72 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.28 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 61.12 | gold quality |
| oocyte | CL:0000023 | 60.79 | gold quality |
| rectum | UBERON:0001052 | 57.27 | gold quality |
| kidney | UBERON:0002113 | 53.70 | gold quality |
| duodenum | UBERON:0002114 | 50.75 | gold quality |
| right testis | UBERON:0004534 | 50.69 | gold quality |
| adenohypophysis | UBERON:0002196 | 50.43 | gold quality |
| hypothalamus | UBERON:0001898 | 50.40 | gold quality |
| testis | UBERON:0000473 | 49.87 | gold quality |
| left testis | UBERON:0004533 | 49.72 | gold quality |
| pituitary gland | UBERON:0000007 | 49.62 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 48.20 | gold quality |
| transverse colon | UBERON:0001157 | 48.12 | gold quality |
| gall bladder | UBERON:0002110 | 47.17 | gold quality |
| putamen | UBERON:0001874 | 47.04 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 46.99 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.56 | gold quality |
| nucleus accumbens | UBERON:0001882 | 45.53 | gold quality |
| small intestine | UBERON:0002108 | 45.34 | gold quality |
| islet of Langerhans | UBERON:0000006 | 44.38 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 44.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 44.03 | gold quality |
| metanephros cortex | UBERON:0010533 | 44.02 | gold quality |
| cortex of kidney | UBERON:0001225 | 43.98 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting TRPC7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-133A-5P | 99.28 | 69.13 | 941 |
| HSA-MIR-3127-3P | 98.94 | 67.34 | 1055 |
| HSA-MIR-6756-3P | 98.94 | 66.79 | 1104 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-1237-5P | 95.38 | 62.21 | 451 |
| HSA-MIR-4488 | 95.38 | 62.00 | 443 |
| HSA-MIR-4697-5P | 95.38 | 61.72 | 457 |
| HSA-MIR-6774-3P | 89.14 | 65.20 | 68 |
Literature-anchored findings (GeneRIF, showing 11)
- Cloning and functional expression of human short TRP7, a candidate protein for store-operated Ca2+ influx (PMID:11805119)
- can be activated by both receptor- and store-operated modes in the same cell. (PMID:15342342)
- endogenous TRPC1, TRPC3, and TRPC7 participate in forming heteromeric store-operated channels, whereas TRPC3 and TRPC7 can also participate in forming heteromeric receptor-operated channels. (PMID:15972814)
- in B-lymphocytes, TRPC7 appears to participate in the formation of ion channels that could be activated by phospholipase C-linked receptors (PMID:16123040)
- activation of both muscarinic and purinergic receptors via a common DAG-dependent link opens Ca(2+)-permeable TRPC7 channels (PMID:16741513)
- the physiological importance of TRPC7 in the native environment remains elusive, TRPC7 would play important roles in Ca2+ signaling pathway–{REVIEW} (PMID:17217055)
- Expression and activity of TRPM7 is modulated by extracellular Mg2+ and Ca2+ availability, indicating that TRPM7 channels are involved in intracellular ion homeostasis and proliferation of osteoblasts. (PMID:18021175)
- heteromeric cation channels comprised of the TRPP2 mutant and the TRPC3 or TRPC7 protein induce enhanced receptor-activated Ca(2+) influx that may lead to dysregulated cell growth in ADPKD (PMID:19812035)
- Phosphorylation of transient receptor potential cation channel subfamily C member 7 significantly suppressed carbachol-induced calcium influx and CREB phosphorylation. (PMID:21402151)
- A fundamental role for PI(4,5)P2 was identified in the regulation of TRPC7 and TRPC6. (PMID:24470487)
- Nociceptive transient receptor potential canonical 7 (TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B. (PMID:31755176)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | trpc7a | ENSDARG00000027523 |
| danio_rerio | trpc7b | ENSDARG00000079469 |
| mus_musculus | Trpc7 | ENSMUSG00000021541 |
| rattus_norvegicus | Trpc7 | ENSRNOG00000012727 |
| caenorhabditis_elegans | WBGENE00006614 |
Paralogs (5): TRPC5 (ENSG00000072315), TRPC4 (ENSG00000133107), TRPC6 (ENSG00000137672), TRPC3 (ENSG00000138741), TRPC1 (ENSG00000144935)
Protein
Protein identifiers
Short transient receptor potential channel 7 — Q9HCX4 (reviewed: Q9HCX4)
Alternative names: Transient receptor protein 7
All UniProt accessions (4): Q9HCX4, A1A4Z5, Q70T24, Q70T25
UniProt curated annotations — full annotation on UniProt →
Function. Forms a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Activated by diacylglycerol (DAG). May also be activated by intracellular calcium store depletion.
Subunit / interactions. Interacts with MX1 and RNF24. Interacts (via ANK-repeat domains) with PRKG1.
Subcellular location. Cell membrane. Nucleus envelope.
Post-translational modifications. Phosphorylation by PRKG1 at Thr-15 negatively regulates TRPC7 activity.
Similarity. Belongs to the transient receptor (TC 1.A.4) family. STrpC subfamily. TRPC7 sub-subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9HCX4-1 | 1 | yes |
| Q9HCX4-2 | 2 | |
| Q9HCX4-3 | 3 |
RefSeq proteins (4): NP_001161048, NP_001161049, NP_001363830, NP_065122* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR002153 | TRPC_channel | Family |
| IPR005463 | TRPC7_channel | Family |
| IPR005821 | Ion_trans_dom | Domain |
| IPR013555 | TRP_dom | Domain |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
Pfam: PF00520, PF08344, PF12796
Catalyzed reactions (Rhea), 1 shown:
- Ca(2+)(in) = Ca(2+)(out) (RHEA:29671)
UniProt features (26 total): topological domain 7, transmembrane region 6, repeat 4, splice variant 2, sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HCX4-F1 | 81.97 | 0.41 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 15
Glycosylation sites (1): 514
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-114508 | Effects of PIP2 hydrolysis |
| R-HSA-139853 | Elevation of cytosolic Ca2+ levels |
| R-HSA-3295583 | TRP channels |
| R-HSA-418890 | Role of second messengers in netrin-1 signaling |
MSigDB gene sets: 87 (showing top):
GOBP_SINGLE_FERTILIZATION, GOBP_TRANSITION_METAL_ION_TRANSPORT, REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION, GGGTGGRR_PAX4_03, GOBP_MONOATOMIC_CATION_TRANSPORT, REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS, GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOBP_FERTILIZATION, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_NUCLEAR_ENVELOPE, chr5q31, GOBP_HOMEOSTATIC_PROCESS
GO Biological Process (8): manganese ion transport (GO:0006828), single fertilization (GO:0007338), regulation of cytosolic calcium ion concentration (GO:0051480), calcium ion transmembrane transport (GO:0070588), monoatomic ion transport (GO:0006811), calcium ion transport (GO:0006816), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085)
GO Molecular Function (5): calcium channel activity (GO:0005262), store-operated calcium channel activity (GO:0015279), inositol 1,4,5 trisphosphate binding (GO:0070679), monoatomic ion channel activity (GO:0005216), protein binding (GO:0005515)
GO Cellular Component (6): nuclear envelope (GO:0005635), plasma membrane (GO:0005886), cation channel complex (GO:0034703), perinuclear region of cytoplasm (GO:0048471), nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| G alpha (q) signalling events | 1 |
| Platelet activation, signaling and aggregation | 1 |
| Platelet calcium homeostasis | 1 |
| Stimuli-sensing channels | 1 |
| Netrin-1 signaling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| cellular anatomical structure | 2 |
| transition metal ion transport | 1 |
| fertilization | 1 |
| intracellular calcium ion homeostasis | 1 |
| calcium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| cellular process | 1 |
| monoatomic cation channel activity | 1 |
| calcium ion transmembrane transporter activity | 1 |
| calcium channel activity | 1 |
| anion binding | 1 |
| alcohol binding | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| channel activity | 1 |
| binding | 1 |
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| membrane | 1 |
| cell periphery | 1 |
| monoatomic ion channel complex | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
480 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRPC7 | TAC1 | P20366 | 885 |
| TRPC7 | TXNDC17 | Q9BRA2 | 772 |
| TRPC7 | GNRH2 | O43555 | 764 |
| TRPC7 | TAC3 | Q9UHF0 | 669 |
| TRPC7 | GRP | P07491 | 665 |
| TRPC7 | TACR1 | P25103 | 644 |
| TRPC7 | GNRH1 | P01148 | 622 |
| TRPC7 | TRPC4 | Q9UBN4 | 598 |
| TRPC7 | DLD | P09622 | 591 |
| TRPC7 | TACR2 | P21452 | 571 |
| TRPC7 | MDM4 | O15151 | 560 |
| TRPC7 | THRB | P10828 | 525 |
| TRPC7 | PYCR1 | P32322 | 508 |
| TRPC7 | SELL | P14151 | 508 |
| TRPC7 | TACR3 | P29371 | 507 |
| TRPC7 | NMB | P08949 | 507 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRPC7 | MX1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRPC3 | SEC24A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): FKBP1A (Affinity Capture-Western), TRPC7 (Affinity Capture-Western), TRPC7 (FRET), TRPC7 (FRET), TRPC7 (FRET), TRPC7 (Reconstituted Complex), TRPC7 (Affinity Capture-MS)
ESM2 similar proteins: A0A8I3S9V6, A0M8U1, A6NH52, E1BWM5, O35089, P13666, P86050, Q00765, Q0VCK9, Q0X0A5, Q1RLU8, Q29S14, Q2PG42, Q3KNM2, Q3ZC24, Q5BJU5, Q5M7T4, Q5R9I4, Q5R9K4, Q5RE33, Q5T4T1, Q5ZJ41, Q5ZJD7, Q6DD32, Q6GM44, Q6NYF1, Q6P360, Q6PI25, Q7TQ48, Q86TD4, Q8C407, Q8L5Y9, Q8MK44, Q8R1Z9, Q91ZQ0, Q940S0, Q96GC9, Q99K70, Q99KU0, Q9BSR8
Diamond homologs: A2A259, H2LRU7, O35245, Q13563, Q4GZT3, Q6IVV8, Q9HCX4, Q9JLG4, Q9NZM6, Q9P0L9, Q9U1S7, Q9WVC5, O18784, O35119, O62826, O62852, P19334, P34586, P48994, P48995, P79100, Q13507, Q61056, Q61143, Q9JMI9, Q9MYV9, Q9MYW0, Q9QUQ5, Q9QX01, Q9QX29, Q9QZC1, Q9R244, Q9R283, Q9TUN9, Q9UBN4, Q9UL62, Q9VJJ7, Q9Y210, O54935, P18887
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PRKG1 | “up-regulates activity” | TRPC7 | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
109 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 100 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
5713 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:136213556:A:G | L823P | 1.000 |
| 5:136213565:C:G | R820P | 1.000 |
| 5:136213566:G:T | R820S | 1.000 |
| 5:136213568:A:G | L819P | 1.000 |
| 5:136213570:G:C | S818R | 1.000 |
| 5:136213570:G:T | S818R | 1.000 |
| 5:136213572:T:G | S818R | 1.000 |
| 5:136213575:A:G | S817P | 1.000 |
| 5:136213577:A:C | I816S | 1.000 |
| 5:136213577:A:T | I816N | 1.000 |
| 5:136213580:T:A | D815V | 1.000 |
| 5:136213580:T:C | D815G | 1.000 |
| 5:136213580:T:G | D815A | 1.000 |
| 5:136213581:C:G | D815H | 1.000 |
| 5:136213583:T:G | Q814P | 1.000 |
| 5:136213585:C:A | K813N | 1.000 |
| 5:136213585:C:G | K813N | 1.000 |
| 5:136213587:T:C | K813E | 1.000 |
| 5:136213589:A:C | I812S | 1.000 |
| 5:136213589:A:G | I812T | 1.000 |
| 5:136213589:A:T | I812N | 1.000 |
| 5:136216249:T:A | R790S | 1.000 |
| 5:136216249:T:G | R790S | 1.000 |
| 5:136216259:A:G | L787P | 1.000 |
| 5:136226215:A:G | L694P | 1.000 |
| 5:136226222:C:G | A692P | 1.000 |
| 5:136226224:C:G | R691P | 1.000 |
| 5:136226229:G:C | F689L | 1.000 |
| 5:136226229:G:T | F689L | 1.000 |
| 5:136226230:A:G | F689S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000037447 (5:136302254 A>G), RS1000058081 (5:136360790 A>C,G), RS1000060337 (5:136348748 C>G,T), RS1000088081 (5:136263281 A>G), RS1000110806 (5:136303370 C>T), RS1000119740 (5:136345827 T>C), RS1000131524 (5:136360560 G>A), RS1000157940 (5:136322607 G>C), RS1000181013 (5:136304230 T>A,C), RS1000190480 (5:136252743 T>G), RS1000194704 (5:136266080 A>T), RS1000198858 (5:136220525 C>T), RS1000214949 (5:136227460 G>A), RS1000262063 (5:136311413 G>A), RS1000301306 (5:136213946 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4105799 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: vgic — Transient Receptor Potential channels (TRP)
Most potent curated ligand interactions (5 total), top 5:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| SH045 | Channel blocker | 6.66 | pIC50 |
| SAR7334 | Channel blocker | 6.65 | pIC50 |
| larixyl acetate | Inhibition | 6.3 | pIC50 |
| BI 749327 | Antagonist | 6.3 | pIC50 |
| pyrazolopyrimidine 4n | Activation | 6.05 | pIC50 |
ChEMBL bioactivities
7 potent at pChembl≥5 of 7 total, top 7 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.05 | EC50 | 90 | nM | CHEMBL4085233 |
| 6.67 | EC50 | 213 | nM | CHEMBL4060387 |
| 6.65 | IC50 | 226 | nM | CHEMBL4129809 |
| 6.50 | EC50 | 314 | nM | CHEMBL4060400 |
| 6.30 | EC50 | 497 | nM | CHEMBL1496110 |
| 5.95 | EC50 | 1130 | nM | CHEMBL1496110 |
| 5.47 | IC50 | 3400 | nM | CHEMBL5561986 |
PubChem BioAssay actives
7 with measured affinity, of 15 total; 6 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| ethyl 4-[2-methyl-7-oxo-3-[4-(trifluoromethyl)phenyl]-1H-pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-1-carboxylate | 1447383: Agonist activity at human TRPC7 expressed in HEK293 cells assessed as increase in intracellular calcium level measured for 2.5 mins in presence of 2 mM Ca2+ by Fluo8-AM dye-based fluorescence assay | ec50 | 0.0900 | uM |
| benzyl 4-[3-(4-chlorophenyl)-2-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-1-carboxylate | 1447383: Agonist activity at human TRPC7 expressed in HEK293 cells assessed as increase in intracellular calcium level measured for 2.5 mins in presence of 2 mM Ca2+ by Fluo8-AM dye-based fluorescence assay | ec50 | 0.2130 | uM |
| 4-[[(1R,2R)-2-[(3R)-3-aminopiperidin-1-yl]-2,3-dihydro-1H-inden-1-yl]oxy]-3-chlorobenzonitrile | 1578752: Inhibition of human TRPC7 expressed in HEK293 cells assessed as reduction in OAG-induced calcium influx after 10 mins by fluo-4/AM dye based FLIPR assay | ic50 | 0.2260 | uM |
| benzyl 4-[3-(4-fluorophenyl)-2-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-1-carboxylate | 1447383: Agonist activity at human TRPC7 expressed in HEK293 cells assessed as increase in intracellular calcium level measured for 2.5 mins in presence of 2 mM Ca2+ by Fluo8-AM dye-based fluorescence assay | ec50 | 0.3140 | uM |
| ethyl 4-[3-(4-fluorophenyl)-2-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-1-carboxylate | 1447383: Agonist activity at human TRPC7 expressed in HEK293 cells assessed as increase in intracellular calcium level measured for 2.5 mins in presence of 2 mM Ca2+ by Fluo8-AM dye-based fluorescence assay | ec50 | 0.4970 | uM |
| 2-[2-aminoethyl(naphthalen-2-ylmethyl)amino]-N-(4-hydroxyphenyl)-1,3-thiazole-4-carboxamide | 2079975: Antagonist activity at human TRPC7 stably expressed in HEK293 cells inhibition of calcium influx by calcium fluorescence assay | ic50 | 3.4000 | uM |
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| microcystin RR | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Dinoprostone | increases response to substance | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
ChEMBL screening assays
14 unique, capped per target: 14 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4015194 | Binding | Agonist activity at human TRPC7 expressed in HEK293 cells assessed as increase in membrane depolarization measured for 2.5 mins in presence of 2 mM Ca2+ by FLIPR membrane potential dye-based fluorescence assay | Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Amiloride